Jvmg. Bovee et al., Molecular genetic characterization of both components of a dedifferentiated chondrosarcoma, with implications for its histogenesis, J PATHOLOGY, 189(4), 1999, pp. 454-462
Citations number
35
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
Dedifferentiated chondrosarcoma is defined as a high-grade, anaplastic sarc
oma adjacent to a low-grade malignant cartilage-forming tumour. Controversy
remains as to whether the anaplastic and cartilaginous components are deri
ved from a common precursor cell, or whether they represent separate genoty
pic lineages (collision tumour). Both components of a case of dedifferentia
ted chondrosarcoma mere therefore separately investigated by loss of hetero
zygosity (LOH) analysis, comparative genomic hybridization (CGH), DNA how c
ytometry, and p53 analysis. Both showed p53 overexpression and an identical
somatic 6 bp deletion in exon 7 of p53. Combination of the CGH and LOH res
ults revealed that both components had lost the same copy of chromosome 13.
These results provide compelling evidence in this case for a common origin
, instead of the 'collision tumour' theory. Certain genotypic alterations m
ere not shared. The anaplastic component showed severe aneuploidy, LOH at a
dditional loci, and amplification and deletion of several chromosome parts.
In contrast, the cartilaginous component had lost chromosomes 5, 22, 17p a
nd part of 16p and revealed an amplification of 17q. The LOH and CGH result
s further demonstrated that the two components had lost a different copy of
chromosome 4. Thus, a substantial number of genetic alterations have occur
red after the diversion of the two components, indicating that the separati
on of the two clones, derived from a single precursor, was a relatively ear
ly event in the histogenesis of this case of dedifferentiated chondrosarcom
a. Copyright (C) 1999 John Whey & Sons, Ltd.